Table 1 Basic characteristics and medical comorbidities of patients undergoing THA
THA after fixation failure | Primary THA | p value | |
|---|---|---|---|
No. of patients | 105 | 210 | – |
Sex (male/female) | (55/50) | (110/100) | 1.00 |
Age | 62.8 (17.9) | 62.8 (17.7) | 0.987 |
Follow-up years | 1.9 (1.7) | 1.4 (1.6) | 0.004* |
Medical history | |||
Diabetes mellitus | 20 (19%) | 24 (11.4%) | 0.066 |
Hypertension | 46 (43.8%) | 95 (45.2%) | 0.81 |
Coronary artery disease | 4 (3.8%) | 12 (5.7%) | 0.468 |
Chronic kidney disease | 10 (9.5%) | 13 (6.2%) | 0.284 |
Cerebrovascular accident | 8 (7.6%) | 2 (1%) | 0.001* |
Rheumatoid arthritis | 3 (2.9%) | 4 (1.9%) | 0.589 |
Peptic ulcer disease | 10 (9.5%) | 13 (6.2%) | 0.284 |
Obesity | 3 (2.9%) | 2 (1%) | 0.202 |
Systemic lupus erythematosus | 1 (1%) | 4 (1.9%) | 0.524 |
Malignancy (cancer) | 8 (7.6%) | 19 (9%) | 0.669 |
Death during follow-up period | 4 (3.8%) | 5 (2.4%) | 0.473 |